Literature DB >> 18684308

MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study.

A Krasnianski1, K Kallenberg, D A Collie, B Meissner, W J Schulz-Schaeffer, U Heinemann, D Varges, D M Summers, H A Kretzschmar, T Talbot, R G Will, I Zerr.   

Abstract

BACKGROUND AND
PURPOSE: To establish radiological features in the atypical MV2 subtype of sCJD compared with the classical MM1 subtype, as well as region- and sequence-dependent inter-observer correlation.
METHODS: MRI hyperintensity of basal ganglia (BG), cortex and thalamus was evaluated in 31 MM1 and 32 MV2 patients. Each MR scan was analyzed independently by two neuroradiologists blinded to PRNP genotype/prion protein type.
RESULTS: Cumulative T2-sensitivity for BG hyperintensity was higher in the MV2 subtype (84% for both observers versus 61% in observer 1/42% in observer 2 in MM1 patients). Significant inter-observer agreement was found for BG and thalamus on T2, FLAIR, PD and DWI, but for cortex only on DWI. Thalamic changes were significantly more frequent in MV2 than in MM1 patients (cumulative sensitivity 86% vs. 12.5% on DWI). DISCUSSION: The high frequency of thalamic hyperintensity in the MV2 subtype allowed differentiation from MM1 patients. Good inter-observer agreement was found for BG and thalamus in all sequences. DWI showed the highest inter-observer correlation independent of the investigated brain region and was therefore not only highly sensitive but also relatively independent of investigator bias. Since inter-observer correlation for cortical hyperintensity in T2, FLAIR and PD is relatively low, the cortical changes should not be over-interpreted with these sequences.

Entities:  

Mesh:

Year:  2008        PMID: 18684308     DOI: 10.1111/j.1468-1331.2008.02209.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

1.  Diagnostic value of diffusion-weighted brain magnetic resonance imaging in patients with sporadic Creutzfeldt-Jakob disease: a systematic review and meta-analysis.

Authors:  Ho Young Park; Minjae Kim; Chong Hyun Suh; Sang Yeong Kim; Woo Hyun Shim; Sang Joon Kim
Journal:  Eur Radiol       Date:  2021-05-12       Impact factor: 5.315

2.  Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases.

Authors:  Damien Galanaud; S Haik; M G Linguraru; J-P Ranjeva; B Faucheux; E Kaphan; N Ayache; J Chiras; P Cozzone; D Dormont; J-P Brandel
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-29       Impact factor: 3.825

3.  Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging.

Authors:  Alberto Bizzi; Riccardo Pascuzzo; Janis Blevins; Marina Grisoli; Raffaele Lodi; Marco E M Moscatelli; Gianmarco Castelli; Mark L Cohen; Lawrence B Schonberger; Aaron Foutz; Jiri G Safar; Brian S Appleby; Pierluigi Gambetti
Journal:  JAMA Neurol       Date:  2020-09-01       Impact factor: 18.302

Review 4.  Neuroradiology of human prion diseases, diagnosis and differential diagnosis.

Authors:  Simona Gaudino; Emma Gangemi; Raffaella Colantonio; Annibale Botto; Emanuela Ruberto; Rosalinda Calandrelli; Matia Martucci; Maria Gabriella Vita; Carlo Masullo; Alfonso Cerase; Cesare Colosimo
Journal:  Radiol Med       Date:  2017-01-21       Impact factor: 3.469

5.  Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.

Authors:  Wen-Quan Zou; Gianfranco Puoti; Xiangzhu Xiao; Jue Yuan; Liuting Qing; Ignazio Cali; Miyuki Shimoji; Jan P M Langeveld; Rudy Castellani; Silvio Notari; Barbara Crain; Robert E Schmidt; Michael Geschwind; Stephen J Dearmond; Nigel J Cairns; Dennis Dickson; Lawrence Honig; Juan Maria Torres; James Mastrianni; Sabina Capellari; Giorgio Giaccone; Ermias D Belay; Lawrence B Schonberger; Mark Cohen; George Perry; Qingzhong Kong; Piero Parchi; Fabrizio Tagliavini; Pierluigi Gambetti
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

Review 6.  Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease.

Authors:  Mark P Figgie; Brian S Appleby
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

7.  Subtype Diagnosis of Sporadic Creutzfeldt-Jakob Disease with Diffusion Magnetic Resonance Imaging.

Authors:  Alberto Bizzi; Riccardo Pascuzzo; Janis Blevins; Marco E M Moscatelli; Marina Grisoli; Raffaele Lodi; Fabio M Doniselli; Gianmarco Castelli; Mark L Cohen; Aymeric Stamm; Lawrence B Schonberger; Brian S Appleby; Pierluigi Gambetti
Journal:  Ann Neurol       Date:  2020-12-22       Impact factor: 10.422

8.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  I Zerr; K Kallenberg; D M Summers; C Romero; A Taratuto; U Heinemann; M Breithaupt; D Varges; B Meissner; A Ladogana; M Schuur; S Haik; S J Collins; Gerard H Jansen; G B Stokin; J Pimentel; E Hewer; D Collie; P Smith; H Roberts; J P Brandel; C van Duijn; M Pocchiari; C Begue; P Cras; R G Will; P Sanchez-Juan
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

9.  Enhanced detection of diffusion reductions in Creutzfeldt-Jakob disease at a higher B factor.

Authors:  H Lee; C Hoffman; P B Kingsley; A Degnan; O Cohen; I Prohovnik
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 4.966

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.